Description: Critical illness policies pay a large lump sum based upon diagnosis of conditions such as heart attack, stroke, life-threatening cancer, kidney failure, etc. From Record of Society of Actuaries, Volume 26, No. 1, session 119PD of the Las Vegas Spring Meeting.

Description: Panelists examine various types of critical illness plans, its success in Canada and other markets, and the challenges and opportunities for the U.S. market.

Description: Panelists address current issues of critical illness products including underwriting, state filing, distribution and marketing. From the Record of the Society of Actuaries, Volume 28, No. 1, Session 33

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products such as specific and employer stop loss, provider excess and critical illness. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 117

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: This panel discussion addresses Critical Illness product design, marketing, trends and lessons learned from other countries. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 20

Description: Stale portfolio got your sales down? In this session, you'll learn about the latest and greatest in product development trends and innovations which you can use to refresh and revitalize your products. At the conclusion of this session, attendees will have a better understanding on market trends in product development as well as leading innovations.

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products. Liabilities for losses that have been incurred but not reported and for losses that have been reported but not paid are examined. Includes a discussion on employer specific stop-loss, provider excess loss, critical illness and cancer insurance. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 133

Description: Panel members provide an overview of current practices and breaking trends in the critical illness market. Topics for discussion include benefit design, pricing considerations, recent experience and long-term outlook for the product. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 47

Description: Panelists discuss the current climate for Critical Illness insurance in the United States. Topics include product design, pricing, underwriting, and marketing high-end products. From Record of Society of Actuaries, Vol. 30, No. 3, Session 11